Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.
Clinical trial NCT03202199 · UNKNOWN
Trial details
- NCT number
- NCT03202199
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2020-01-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.